| Chemar |
04-13-2009 07:42 AM |
FDA Obtains Permanent Injunction Barring Two Companies
Quote:
The U.S. Food and Drug Administration today announced that it had obtained a permanent injunction barring Neilgen Pharmaceuticals Inc. of Westminster, Md., its parent company, Advent Pharmaceuticals, Inc. (Advent), of East Windsor, N.J., and two of their officers, Bharat Patel and Pragna Patel, from manufacturing and distributing any unapproved, adulterated or misbranded drugs.
Both Neilgen, which does business as Unigen Pharmaceuticals Inc. (Unigen), and Advent are contract manufacturers and distributors of more than 25 different unapproved drug products each. The more than 50 unapproved drug products primarily include prescription cough and cold products..........
|
for the full report and list of drugs please go to
http://www.fda.gov/bbs/topics/NEWS/2009/NEW01995.html |
